Glossary of clinical research

A glossary of terms used in clinical research.

Table of contents: .A | .B | .C | .D | .E | .F | .G | .H | .I | .J | .K | .L | .M | .N | .O | .P | .Q | .R | .S | .T | .U | .V | .W | .X | .Y | .Z

A[edit]

Glossary of Clinical Research (Part 1)[edit]

Active placebo – A placebo designed to mimic the side effects of the treatment being studied, without offering therapeutic benefit. Used to maintain study blinding more effectively.

Adverse event – Any undesirable experience or medical occurrence during a clinical trial, regardless of whether it is related to the investigational treatment.

AllTrials – A global campaign advocating for the registration and reporting of all clinical trial results to improve transparency and public access to research.

Analysis of clinical trials – The process of evaluating clinical trial data to determine safety and efficacy outcomes using statistical methods.

Anne Ferguson (physician) – A noted British physician known for her contributions to gastroenterology and research ethics.

Approved drug – A pharmaceutical drug that has passed regulatory review (e.g., FDA approval) and is authorized for public use.

Assay sensitivity – The ability of a clinical trial to distinguish between effective and ineffective interventions.

Biodistribution – The study of how substances such as drugs spread throughout body tissues and organs after administration.

Bioequivalence – A measure showing that two drugs release their active ingredients into the bloodstream at the same rate and extent.

Biomedical Research Center – An institution dedicated to conducting research in biomedicine, often involving clinical and translational studies.

Blinded experiment – A study design where participants, and sometimes researchers, are unaware of the group assignments to minimize bias.

COVID-19 drug development – The accelerated process of discovering and evaluating therapies and vaccines for the COVID-19 pandemic.

Case report – A detailed description of an individual patient’s medical history, diagnosis, treatment, and outcomes, often used to report novel or rare conditions.

Case report form – A standardized document used to collect clinical data from each participant in a clinical trial.

Case series – A collection of case reports of patients who have a similar condition or received the same treatment, used in observational studies.

Castle Connolly Medical – A health organization that identifies and publishes lists of top doctors and institutions in the United States.

Clinical data acquisition – The collection of accurate and validated clinical data during a trial, typically guided by a protocol.

Clinical data management system – A software tool used to input, clean, and manage data gathered during clinical studies.

Clinical endpoint – A measurable outcome used to assess the effectiveness of a treatment, such as survival rate or symptom relief.

Clinical investigator – A qualified individual responsible for conducting a clinical trial at a specific site in compliance with regulations and ethical standards.

Clinical research associate – A professional who ensures that a clinical trial is conducted according to the protocol and regulatory guidelines, often through site monitoring.

Clinical research coordinator – A key team member who manages day-to-day trial operations including patient recruitment, data entry, and regulatory compliance.

Clinical significance – The practical importance of a treatment effect, meaning how beneficial it is in real-world clinical practice.

Clinical study design – The blueprint for how a clinical study is conducted, including methodology, timelines, and participant selection.

Clinical study report – A comprehensive account of a clinical trial's background, methodology, results, and conclusions, used for regulatory submissions.

Clinical trial – A type of research study that evaluates the safety and efficacy of medical, surgical, or behavioral interventions in humans.

Clinical trial management system – A platform that helps plan, track, and manage operational aspects of clinical trials such as budgets and schedules.

Clinical trial portal – An online interface used by researchers, sponsors, or participants to access and manage clinical trial information.

Clinical trial registration – The public documentation of a clinical trial’s objectives, design, and status in a clinical trial registry before enrollment begins.

Clinical trials publication – The dissemination of clinical trial results in scientific journals or public databases to inform medical knowledge.

Clinical trials unit – A dedicated organizational entity within a hospital or academic center responsible for conducting and supporting clinical trials.

Cluster-randomised controlled trial – A study where groups (rather than individuals) are randomized to different interventions, common in public health research.

Code-break procedure – The predefined method to reveal a participant’s treatment allocation in a blinded study, typically used in emergencies.

Common Technical Document – A harmonized format used to submit drug approval information to international regulatory authorities such as the EMA or FDA.

Community advisory board – A group representing trial participants or affected communities that offers input on trial design and ethical issues.

Community-based clinical trial – A trial conducted in a community setting, often involving diverse populations and focusing on real world evidence.

Consecutive case series – An observational study where patients treated in succession under the same protocol are included without exclusion.

Contract research organization – An external company contracted by sponsors to conduct research services, including trial management and data analysis.

Core outcome set – A standardized set of outcomes that should be measured and reported in all clinical trials for a specific health condition.

Crossover study – A clinical trial in which participants receive treatments in a specific order (e.g., treatment A then B), allowing each participant to act as their own control.

Data clarification form – A document used during data validation to query discrepancies or missing entries in the clinical trial database.

Data monitoring committee – An independent group of experts who monitor the safety and efficacy of a trial and can recommend early termination if necessary.

DecodeME – A UK-based clinical study exploring the genetic basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Dynamic treatment regime – A strategy in clinical research where treatment decisions adapt over time based on patient responses.

Effect size – A statistical measure describing the strength of a treatment effect, often used to interpret clinical importance beyond statistical significance.

Electronic data capture – The process of entering trial data directly into electronic systems, improving efficiency and data accuracy over paper-based forms.

Evidence-based medicine – A clinical practice approach that integrates the best current evidence, clinician expertise, and patient values in decision-making.

Expanded access – A regulatory pathway allowing patients to access investigational therapies outside of clinical trials due to unmet medical needs.

Glossary of Clinical Research (Part 2)[edit]

Good clinical data management practice – Standards and practices aimed at ensuring the integrity, quality, and confidentiality of clinical trial data.

Good clinical practice – An international ethical and scientific quality standard for designing, conducting, and reporting trials that involve human subjects.

Haybittle–Peto boundary – A statistical threshold used in interim analyses of clinical trials to determine whether to stop early for efficacy.

Health services research – A multidisciplinary field studying how healthcare is accessed, its cost, and outcomes, with a goal of improving healthcare systems.

Hierarchy of evidence – A framework ranking the relative strength of various types of clinical research evidence.

Hit selection – A phase in drug discovery where potential therapeutic compounds are identified from high-throughput screening.

Human subject research – Research involving human participants, requiring rigorous ethical oversight and informed consent procedures.

IDEAL framework – A structured model for evaluating new surgical interventions through Innovation, Development, Exploration, Assessment, and Long-term study stages.

In silico clinical trials – Simulated trials conducted using computer modeling to predict the behavior of drugs in virtual populations.

Inclusion and exclusion criteria – The set of predefined characteristics used to determine participant eligibility in a clinical study.

Informed assent – An agreement to participate in research obtained from individuals (often minors) not legally able to give full informed consent.

Intention-to-treat analysis – A strategy for analyzing results in clinical trials where all participants are included in the group to which they were originally assigned.

Interim analysis – The evaluation of trial data at intervals before completion to monitor safety and potential efficacy.

Investigational New Drug – A drug not yet approved for general use but allowed for clinical investigation by regulatory bodies like the FDA.

Investigator's brochure – A detailed compilation of clinical and non-clinical data on an investigational product for investigators in a trial.

Irwin screen – A standardized method for evaluating behavioral and physiological changes in rodents, often used in preclinical testing.

Jadad scale – A scoring system used to assess the methodological quality of clinical trials, particularly randomized controlled trials.

James Lind – An 18th-century Scottish physician recognized for conducting one of the first controlled clinical trials.

Linguistic validation – The process of translating and culturally adapting clinical instruments to maintain their reliability and validity across languages.

Lost to follow-up – Participants in a clinical trial who are no longer reachable or do not return for evaluation, potentially impacting study results.

Male contraceptive – Birth control methods or drugs developed for men, which are currently under clinical investigation.

Medical statistics – The use of statistical methods to analyze and interpret data in medical and clinical research.

Medical writing – The creation of scientific documentation related to clinical research, including study protocols, reports, and publications.

Microdosing – Administering subtherapeutic doses of a drug to study its pharmacokinetics in humans, typically in early-phase trials.

Minimisation (clinical trials) – A method of patient allocation in trials that ensures balanced distribution of participants across treatment groups.

Mirandola Biomedical District – An Italian hub for biomedical research and manufacturing, especially in medical devices.

Monitoring in clinical trials – The process of overseeing a clinical trial to ensure that it is conducted according to the protocol, GCP, and regulatory requirements.

Multicenter trial – A clinical trial conducted at more than one location, increasing generalizability and recruitment rates.

NHS Research Scotland – A national organization supporting clinical research in Scotland's National Health Service.

Natural history study – An observational study tracking the course of a disease over time without intervention.

Nocebo – An adverse effect caused by negative expectations of the patient, the opposite of the placebo effect.

Non-specific effect of vaccines – Effects of vaccines that are unrelated to their target disease but impact other aspects of immunity.

Nottingham Health Profile – A health status questionnaire used to assess the impact of disease on quality of life.

Open flow microperfusion – A minimally invasive technique used for sampling interstitial fluid to study drug distribution.

Patient diary – A tool used by clinical trial participants to record symptoms, adherence, and other patient-reported outcomes.

Patient-reported outcome – Any report of the status of a patient's health condition that comes directly from the patient.

Pearl Index – A statistic used to evaluate the effectiveness of a contraceptive method, measured in pregnancies per 100 women-years.

Pharmacovigilance – The science and activities related to detecting, assessing, and preventing adverse effects of pharmaceutical products.

Phases of clinical research – The four stages (Phase I–IV) of clinical trials used to assess safety, efficacy, and post-marketing surveillance of a treatment.

Placebo – A substance or treatment with no therapeutic effect, used as a control in clinical trials.

Placebo in history – The historical use and development of placebos in medical research and clinical practice.

Placebo-controlled study – A clinical trial where the effects of an experimental treatment are compared against a placebo.

Pocock boundary – A statistical stopping rule used during interim analysis to evaluate early efficacy or safety concerns.

Pooled analysis – A method of combining data from multiple studies to increase statistical power and robustness.

Population study – Research that investigates the health outcomes of populations rather than individuals, often used in epidemiology.

Post hoc analysis – An analysis conducted after a study has been completed, often exploratory and not pre-specified in the protocol.

Postmarketing surveillance – The monitoring of a drug's performance and safety after it has been approved and released to the market.

Pragmatic clinical trial – A study designed to evaluate the effectiveness of interventions in real-world clinical settings.

Principal investigator – The lead researcher responsible for the conduct and oversight of a clinical trial at a site.

Prioritization – The process of selecting and ranking clinical studies based on importance, feasibility, or potential impact.

Randomized controlled trial – A trial in which participants are randomly assigned to different treatment groups to reduce bias and establish causality.

Rapid reviews – Accelerated systematic reviews that provide timely evidence synthesis to inform urgent healthcare decisions.

Real world data – Data collected from routine clinical practice or non-trial settings, used to assess treatment outcomes in general populations.

Real world evidence – Clinical evidence derived from analysis of real world data to inform health care decisions.

Remote data capture – A method of electronically collecting clinical trial data from participants outside of the study site.

Remote data entry – The process by which investigators enter trial data directly into an electronic system from remote locations.

Research in Parkinson's disease – A field of clinical research focused on understanding and treating Parkinson's disease.

Response-rate ratio – A metric comparing the proportion of responses between two groups in a clinical trial.

Retrospective cohort study – An observational study using past data to assess outcomes in groups based on previous exposure.

Run-in period – A phase before randomization in a clinical trial used to assess participant compliance and stabilize conditions.

Safety monitoring – The ongoing review of adverse events and other safety-related data in a clinical trial to protect participants.

Serious adverse event – An adverse event that results in death, is life-threatening, or causes significant disability or hospitalization.

Sham surgery – A placebo surgical procedure used to control for placebo effects in trials evaluating surgical interventions.

Solidarity trial – A multinational WHO-led clinical trial designed to evaluate COVID-19 treatments quickly and efficiently.

Solomon four-group design – An experimental design used to control for the effects of pretesting on the results of a study.

Sorby Research Institute – A British research institute known for conducting human nutrition and clinical trials during WWII.

Source document – The original record containing the data collected during a clinical trial, used to verify accuracy and integrity.

Standard operating procedure – A set of written instructions that describe routine processes and practices in clinical research.

Standard treatment – The currently accepted and widely used treatment for a specific condition, often used as a comparator in trials.

Stepped-wedge trial – A type of randomized controlled trial where all participants receive the intervention in a staggered manner over time.

Subjective report – A personal account of symptoms or outcomes provided by the trial participant, often used in patient-reported outcomes.

Treatment and control groups – Groups in a trial where one receives the experimental intervention and the other receives standard care or placebo.

Vaccine trial – A clinical trial conducted to assess the safety, immunogenicity, and efficacy of a vaccine.

Validation (drug manufacture) – The documented process of proving that a drug manufacturing process consistently produces a product meeting its quality standards.

Zelen's design – A randomized clinical trial design where consent is obtained after randomization, used to reduce bias.

Glossaries, dictionaries, and lists in WikiMD[edit]

Popular Glossaries	Dictionaries	Lists & Glossaries	Topics
Medicine Drugs Vaccines Biology Bacteriology Psychiatry Diabetes Genetics General Health Obesity Microbiology Epidemiology Dermatology Simple English	Dictionary of Medicine Concise Dictionary Cancer Diet General Medicine Patient Safety Pediatrics Influenza Health Topics Deafness Biology Allied Microbiology Emergency Medicine	Food and Beverage Antibiotic Resistance Dietary Supplements Food Terms Women's Health TB Terms Pediatrics Malaria Infection Control Medical Terms Pharmacology Occupational Rheumatology	Gynecology Anatomy Nutrient Labels Diet Pediatrics Addiction Medicine Short Glossary Biochemistry Cardiology Neurology Pathology Research Health A-Z

Additional Resources:[edit]